How is cutaneous amyloidosis treated?

　　In general, amyloidosis cutis may be caused by genetic factors, metabolic disorders, external stimulation, chronic inflammation, multiple myeloma, and other reasons. Patients can undergo treatments such as avoiding behaviors that stimulatestimulate the skin, medication, and surgery. Specific treatments are as follows:

　　1. Genetic factors: Amyloidosis cutis has a genetic predisposition, especially with a clear autosomal dominant inheritance pattern. This means other family members may also suffer from this disease, showing familial clustering. Treatment should follow medical advice and may include topical medications such as tretinoin cream, calcipotriol cream, and mometasone furoate cream.

　　2. Metabolic disorders: Metabolic disorders, possibly caused by gene mutations, reduced enzyme activity, and other factors, are one of the important causes of amyloidosis cutis. When the metabolism of protein precursors in the body becomes abnormal, it may lead to abnormal deposition of amyloid proteins in skin tissues. Medications should be used following medical advice, such as atorvastatin calcium tablets, simvastatin tablets, fenofibrate tablets, etc.

　　3. External stimulation: Long-term and repeated mechanical stimulation, such as scratching and friction, may damage skin cells, thereby promoting the synthesis and deposition of amyloid proteins. Such external stimulation is more common in patients with neuroses or individuals with specific lifestyle habits. One should avoid excessive scratching, rubbing, and other behaviors that stimulate the skin, and maintain clean and moisturized skin.

　　4. Chronic inflammation: Some chronic inflammatory diseases, such as chronic dermatitis and eczema, may cause skin damage, providing conditions for the deposition of amyloid proteins. These inflammatory diseases may indirectly promote the occurrence of amyloidosis cutis by affecting the metabolism and immune function of skin cells. Anti-inflammatory medications such as azithromycin enteric-coated capsules, cefalexin sustained-release capsules, levofloxacin hydrochloride capsules, etc., can be used following medical advice.

　　5. Multiple myeloma: Multiple myeloma is a malignant tumor originating from plasma cells in the bone marrow. This disease may lead to metabolic disturbances or immune dysfunction, thereby promoting the deposition of amyloid proteins in the skin. Treatment should be conducted under a doctor's guidance, including surgical procedures such as tumor resection, open reduction, and internal fixation, followed by chemotherapy after surgery.

　　Maintaining good lifestyle habits and a positive mindset in daily life can help control the disease and alleviate symptoms.